Finance

Lists
Why is BOT down ၅.၅၆%?
Dive Deeper
BOT:ASX
Botanix Pharmaceuticals Ltd
၀.၀၁၇ A$
-၅.၅၆%
(-၀.၀၀၁၀၀) 1D
အောက် ၅, GMT+၁၁ ၁၆:၁၀:၀၈  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for BOT...
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
Open
၀.၀၂ A$
High
၀.၀၂ A$
Low
၀.၀၂ A$
Mkt. cap
၄.၂၃ ကုဋေ
Avg. vol.
၆.၄၁ သန်း
Volume
၀.၀၀
52-wk high
၀.၁၇ A$
52-wk low
၀.၀၂ A$
EPS
-၀.၀၃ A$
Shares outstanding
၂၇၆.၁၅ ဋေ
No. of employees
၁၁
News stories
From web sources and news partners
The Business Journals
The Business Journals
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
Georgia Banking Co. plans to go public as it sees a void in the market amid industry consolidation
ChartMill
ChartMill
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
Monday's session: top gainers and losers in the dow jones index
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၁၈ မိနစ်
Helen of Troy (NASDAQ:HELE) Stock Price Down 5.8% - Time to Sell?
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Is the economy awful? S&P 500 and job market say otherwise
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees၁၁
Founded၁၉၈၄
Headquarters-
Sector-
Last report
၂၀၂၆ ဇူ ၂၇
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
၈.၆၅ သန်း / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၈.၂၅ သန်း
၈.၂၅ သန်း
၈.၆၅ သန်း
၈.၆၅ သန်း
Cost of goods sold
၂.၉၈ သန်း
၂.၉၈ သန်း
၄.၁၉ သန်း
၄.၁၉ သန်း
Cost of revenue
၂.၉၈ သန်း
၂.၉၈ သန်း
၄.၁၉ သန်း
၄.၁၉ သန်း
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၈၃ ကုဋေ
၁.၈၃ ကုဋေ
၁.၉၇ ကုဋေ
၁.၉၇ ကုဋေ
Operating expense
၂.၂၁ ကုဋေ
၂.၂၁ ကုဋေ
၂.၂၃ ကုဋေ
၂.၂၃ ကုဋေ
Total operating expenses
၂.၅၁ ကုဋေ
၂.၅၁ ကုဋေ
၂.၆၅ ကုဋေ
၂.၆၅ ကုဋေ
Operating income
-၁.၆၈ ကုဋေ
-၁.၆၈ ကုဋေ
-၁.၇၈ ကုဋေ
-၁.၇၈ ကုဋေ
Other non operating income
၆.၈၃ သိန်း
၆.၈၃ သိန်း
၁.၀၉ သိန်း
၁.၀၉ သိန်း
EBT including unusual items
-၁.၆၆ ကုဋေ
-၁.၆၆ ကုဋေ
-၁.၈၃ ကုဋေ
-၁.၈၃ ကုဋေ
EBT excluding unusual items
-၁.၆၆ ကုဋေ
-၁.၆၆ ကုဋေ
-၁.၈၃ ကုဋေ
-၁.၈၃ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၆၆ ကုဋေ
-၁.၆၆ ကုဋေ
-၁.၈၃ ကုဋေ
-၁.၈၃ ကုဋေ
Net profit margin
-၂၀၁.၁၁%
-၂၀၁.၁၁%
-၂၁၁.၄၆%
-၂၁၁.၄၆%
Earnings per share
-
-
-
-
Interest and investment income
၃.၅၃ သိန်း
၃.၅၃ သိန်း
၂.၀၂ သိန်း
၂.၀၂ သိန်း
Interest expense
-၈.၀၂ သိန်း
-၈.၀၂ သိန်း
-၆.၁၆ သိန်း
-၆.၁၆ သိန်း
Net interest expenses
-၄.၅၀ သိန်း
-၄.၅၀ သိန်း
-၄.၁၄ သိန်း
-၄.၁၄ သိန်း
Depreciation and amortization charges
၅.၉၃ သိန်း
၅.၉၃ သိန်း
၅.၆၅ သိန်း
၅.၆၅ သိန်း
EBITDA
-၁.၆၂ ကုဋေ
-၁.၆၂ ကုဋေ
-၁.၇၃ ကုဋေ
-၁.၇၃ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ